Cancer Biological Therapy Market 2025 to 2034
Cancer Biological Therapy Market 2025 to 2034
Cancer Biological Therapy Market (By Type: Antibodies, Vaccines, Cancer Growth Blockers, Cytokines, Others; By Phases: Phase I, Phase II, Phase III; By Distribution Channel: Specialized Cancer Treatment Centers, Hospitals & Clinics, Retail Pharmacies; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
Customisation Request
Revenue, 2025
USD 124.44 Bn
Forecast Year, 2034
USD 249.17 Bn
CAGR, 2025 - 2034
8.02%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global cancer biological therapy market, valued at USD 124.44 billion in 2025, is projected to reach USD 249.17 billion by 2034, expanding at a CAGR of 8.02%, driven by advancements in targeted therapies and rising cancer prevalence worldwide.
Cancer Biological Therapy Market Size Analysis
Cancer Biological Therapy Market Size By Type 2025 to 2034 (USD Billion)
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Antibodies | 8.43 | 8.99 | 9.72 | 10.43 | 11.34 | 12.31 | 13.33 | 14.33 | 15.44 | 16.77 |
| Vaccines | 16.65 | 17.87 | 19.31 | 21.00 | 22.63 | 24.53 | 26.48 | 28.49 | 30.79 | 33.18 |
| Cancer Growth Blockers | 24.83 | 26.89 | 29.11 | 31.40 | 33.85 | 36.50 | 39.57 | 42.62 | 46.18 | 49.81 |
| Cytokines | 33.11 | 35.90 | 38.75 | 41.86 | 45.25 | 48.81 | 52.60 | 56.94 | 61.48 | 66.54 |
| Others | 41.41 | 44.77 | 48.31 | 52.15 | 56.36 | 60.85 | 65.71 | 71.16 | 76.77 | 82.87 |
Cancer Biological Therapy Market Size By Phases 2025 to 2034 (USD Billion)
| Phases | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase I | 20.89 | 22.50 | 24.26 | 26.06 | 28.33 | 30.94 | 33.29 | 35.65 | 38.64 | 41.53 |
| Phases II | 41.54 | 44.76 | 48.58 | 52.55 | 56.35 | 60.77 | 65.62 | 71.32 | 77.11 | 83.16 |
| Phases III | 62.01 | 67.16 | 72.36 | 78.24 | 84.75 | 91.30 | 98.78 | 106.58 | 114.92 | 124.48 |
Cancer Biological Therapy Market Size By Distribution Channel 2025 to 2034 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Specialized Cancer Treatment Centers | 20.79 | 22.60 | 24.48 | 26.11 | 28.45 | 30.80 | 32.92 | 35.56 | 38.41 | 42.08 |
| Hospitals & Clinics | 41.42 | 44.89 | 48.50 | 52.32 | 56.55 | 60.88 | 65.80 | 71.04 | 77.00 | 82.88 |
| Retail Pharmacies | 62.23 | 66.93 | 72.22 | 78.41 | 84.42 | 91.33 | 98.97 | 106.94 | 115.26 | 124.21 |
Cancer Biological Therapy Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 12.57 | 13.62 | 14.65 | 15.88 | 17.20 | 18.55 | 19.97 | 21.64 | 23.17 | 25.30 |
| LAMEA | 24.91 | 26.81 | 29.06 | 31.39 | 33.91 | 36.54 | 39.56 | 42.62 | 46.37 | 49.68 |
| Europe | 37.29 | 40.35 | 43.54 | 46.97 | 50.81 | 54.94 | 59.38 | 63.90 | 69.05 | 74.51 |
| Asia-Pacific | 49.68 | 53.64 | 57.96 | 62.60 | 67.51 | 72.98 | 78.77 | 85.38 | 92.07 | 99.68 |
Cancer Biological Therapy Market Size to Hit USD 249.17 Billion by 2034
The global cancer biological therapy market size is estimated at USD 124.44 billion in 2025 and is projected to be worth around USD 249.17 billion by 2034 with a growing at a CAGR of 8.02%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
